Dr Christy Goldsmith
Dr Christy Goldsmith undertook a travel fellowship in aspects of SABR in 2009, learning Linac-based technique at the NKI, Amsterdam, and CyberKnife technique at Stanford University hospital, USA. This experience furthered Dr Goldsmith’s interest in SABR technique and she took up a CyberKnife Fellow post at The Harley Street Clinic, London, studying for an MD(Res) thesis on “Optimising dose delivery and tracking accuracy in SABR”. Dr Goldsmith has presented Abstracts on SABR for Oligometastatic disease at ESTRO, ASTRO and the RSS Scientific meeting.
Improving patient outcomes with Stereotactic Ablative Body Radiotherapy (SABR)
SABR is a fairly new Radiotherapy treatment approach. High dose radiotherapy is delivered with pin-point accuracy. Patients typically benefit from improved tumour control, and fewer side effects. The treatment duration is also shorter than “standard” radiotherapy meaning patients can get back to normal life much quicker. SABR will be explained to the audience.
EVEN MORE SEMINARS
Michael Schreiber Brain Tumor Foundation, Chairman
Brain Tumors - Innovation, support and advocacy
Mani Naghibi St. Mark's Hospital
Using nutrition therapies to positively effect cancer treatment outcomes
Dr Matt Brown The Royal Marsden Hospital
Pain in Cancer – New Horizons
Mylaine Riobe MD, FABOIM, FACOG Riobe Institute of Integrative Medicine
Cancer is not random! Evolving mechanisms for cancer causation and prevention
Professor A. Graham Pockley multimmune GmbH / Nottingham Trent University
A new era of cancer therapeutics?